Jade Biosciences Inc. (AVTE)
NASDAQ · Healthcare
Jade Biosciences Inc. EPS 2019–2024
Jade Biosciences Inc. annual/quarterly eps history and growth rate from 2019 to 2024. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Jade Biosciences Inc. eps for the quarter ending September 30, 2024 was $0.56, a 21.13% decrease year-over-year.
- Jade Biosciences Inc. annual eps for 2023 was $2.87, a 36.35% increase from 2022.
- Jade Biosciences Inc. annual eps for 2022 was $2.10, a 12.56% increase from 2021.
- Jade Biosciences Inc. annual eps for 2021 was $1.87, a 95.34% decrease from 2020.
- Jade Biosciences Inc. annual eps for 2020 was $40.17.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Jade Biosciences Inc. EPS — FAQ
Jade Biosciences Inc. (AVTE) eps over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AVTE's eps history?
The chart and table above show Jade Biosciences Inc.'s eps by year and by quarter, including the growth rate.